← All claims

Metabolic & Cardiometabolic · Gut & Microbiome

Akkermansia muciniphila P9 protein induces GLP-1

In plain terms: Can a protein from the gut microbe Akkermansia trigger release of the blood-sugar hormone GLP-1?

Strong support Metabolic & Cardiometabolic 💰 Industry COI noted🔬 Includes disconfirming
RefutedContestedStrong support
consensus score 0.69

Yes, but only shown in animals and lab cells so far, never in people.

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Human trials (RCT / n-of-1)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

11 support 0 contradict 2 tested null 1 mixed · 14 sources, 11 independent groups

What the evidence shows

A. muciniphila's secreted P9 protein induces GLP-1 from L-cells (ICAM-2/IL-6-dependent) and improves glucose tolerance in mice; independently reproduced in vitro. Mouse + cell-line only — no human GLP-1 evidence, and the bacterium is not encouraged by bread starch directly (it feeds on mucin).

The evidence (14)

SourceGradeStanceQualityFinding
Cani
2021 · Cell Metab
mechanism supports moderate [FT-verified] Cani commentary affirms P9->GLP-1; COI authors hold A.muciniphila/A-Mansia patents; commentary not data
Safari
2025 · Probiotics Antimicrob Proteins
mechanism supports low Review: Amuc_1631 (P9) enhances glucose homeostasis by promoting GLP-1 secretion, linking gut microbiota to metabolic regulation.
Depommier C, et al.
2019 · Nat Med
RCT tested-null moderate Proof-of-concept human supplementation of A. muciniphila improved insulin sensitivity/markers; organism whose P9 secretion is proposed GLP-1 mediator.
Di
2025 · 3 Biotech
in-vitro supports moderate Engineered L. lactis secreting A. muciniphila P9 stimulated GLP-1 (GCG/PCSK1 up) in NCI-H716 L-cells; anti-obesity potential in HFD mice.
Dinkov B.
2026 · study_type: observational
mechanism supports low Narrative review (26 studies, 23 preclinical/3 clinical) synthesizing that A. muciniphila enhances endogenous GLP-1 secretion via the P9/ICAM-2 axis, proposed as part of a bidirectional feedback loop with GLP-1 receptor agonist therapies.
Han
2026 · Microorganisms
in-vitro supports moderate Review of A. muciniphila disease-related proteins; catalogs P9 as secreted effector inducing GLP-1 via ICAM-2 signaling in L-cells.
Suenaert
2026 · Gut Microbes
RCT supports moderate Pasteurized A. muciniphila in humans modulated metabolic endpoints consistent with P9/Amuc-driven GLP-1 axis; downstream clinical readout of the mechanism.
Long
2026 · Int J Biol Macromol
mechanism supports low Mechanistic review: P9 mediates host metabolism through ICAM-2/IL-6 signaling driving GLP-1 secretion; biomanufacturing and delivery advances.
Yoon HS, et al.
2021 · Nat Microbiol
animal supports moderate [FT-verified] Yoon 2021 NatMicro P9 induces GLP-1, improves glucose in mice (ICAM-2/IL-6). ANIMAL-ONLY species caveat
(recombinant P9)
2024 · World J Microbiol Biotechnol
in-vitro supports moderate [FT-verified] Di 2024 recombinant L.lactis P9 raised GCG/PCSK1 1.5-1.6x in NCI-H716; independent in-vitro
Arukha AP et al
2025 · study_type: in-vitro
in-vitro mixed low VH A. muciniphila (Vidya Strain) bacterial cell extracts produced a dose-dependent, >2000% rise in GLP-1 secretion from NCI-H716 L-cells and a modest increase in insulin secretion from INS-1 beta cells.
Mazhar
2023 · Foods
observational tested-null low Microbiota-derived signals (incl. bacterial effectors/SCFA) stimulate L-cell GLP-1 via GPR41/43; supports plausibility but not P9-specific.
Nauck
2021 · Diabetes Obes Metab
mechanism supports high Establishes L-cell GLP-1 secretion physiology underpinning claim that a secreted bacterial protein acting on L-cells raises GLP-1.
He
2024 · Foods
observational supports low A. muciniphila functional-component review summarizing P9-mediated GLP-1 stimulation and glucose-homeostasis benefits.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.